Tous les communiqués | WebDisclosure

Switch to English

11293	Sociétés
250967	Mots-clés
179878	Articles
136836	Communiqués

Accueil
Tous les communiqués

COMMUNIQUÉ DE PRESSE

publié le 25/02/2025 à 06:30, il y a 1 année 8 mois

Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®
Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®. Approval for treating retinal diseases granted by UK's MHRA

Regulatory Approval UK Biosimilar Formycon AHZANTIVE
COMMUNIQUÉ DE PRESSE

publié le 25/02/2025 à 05:26, il y a 1 année 8 mois

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3Y Change of Director's Interest Notice
Dexus Finance Pty Limited announces Change of Director's Interest Notice for Rhoda Phillippo. Appendix 3Y form filed to ASX for public disclosure

Real Estate Dexus Finance Pty Limited ASX Release Appendix 3Y Change Of Director's Interest Notice
COMMUNIQUÉ DE PRESSE

publié le 25/02/2025 à 02:20, il y a 1 année 8 mois

UniDoc - Announces Filing of Amended and Restated Interim Management Discussion and Analysis
UniDoc Health Corp. issues amended and restated management's discussion and analysis for clarifying disclosure following continuous disclosure review by the British Columbia Securities Commission

British Columbia Securities Commission Management's Discussion And Analysis UniDoc Health Corp. Amended Clarifying Disclosure
COMMUNIQUÉ DE PRESSE

publié le 25/02/2025 à 00:05, il y a 1 année 8 mois

BluSky Carbon Announces Closing of Convertible Debenture Financing and Unit Offering
BluSky Carbon Inc. closes non-brokered private placement of convertible debentures and completes Unit Offering, raising funds for business development

Private Placement Business Development Convertible Debentures BluSky Carbon Inc. Unit Offering
COMMUNIQUÉ DE PRESSE

publié le 25/02/2025 à 00:00, il y a 1 année 8 mois

Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Onco-Innovations Limited announces successful preclinical study results of its second-generation nanoparticle formulation of PNKP Compound, showing enhanced inhibitor delivery with minimal toxicity for potential cancer therapy

Preclinical Study Cancer Therapy Onco-Innovations Limited Nanoparticle Formulation PNKP Compound
COMMUNIQUÉ DE PRESSE

publié le 24/02/2025 à 22:15, il y a 1 année 8 mois

Kingstone Announces Record Operating Profit and Growth for Fourth Quarter and Full Year 2024
Kingstone Companies, Inc. schedules conference call on March 14 for fourth quarter 2024 financial results. Company's preliminary financial performance highlights significant improvements in direct written premiums and operating income

Financial Results Conference Call Kingstone Companies Inc. Preliminary Performance Direct Written Premiums
COMMUNIQUÉ DE PRESSE

publié le 24/02/2025 à 21:27, il y a 1 année 8 mois

Sanofi : Déclaration des transactions sur actions propres
COMMUNIQUÉ DE PRESSE

publié le 24/02/2025 à 21:27, il y a 1 année 8 mois

Sanofi: Disclosure of trading in own shares
COMMUNIQUÉ DE PRESSE

publié le 24/02/2025 à 21:15, il y a 1 année 8 mois

Shelly achieves a successful financial year 2024 with profitable growth well above the industry average
Shelly Group SE achieves successful financial year 2024 with remarkable growth exceeding industry average, driven by revenue increase and international expansion

Revenue Increase Financial Year 2024 Profitable Growth International Expansion Shelly Group SE
COMMUNIQUÉ DE PRESSE

publié le 24/02/2025 à 21:14, il y a 1 année 8 mois

Inside Information / Other news releases
Pernod Ricard successfully completes €800 million bond issuance with a coupon of 3.25% for general corporate purposes, led by Bank of America and others

Bond Issuance Bank Of America PERNOD RICARD €800 Million Coupon 3.25%

Les Echos

Publié le 06/11/2026 à 19:06, il y a 1 jour 4 heures

ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Publié le 06/11/2026 à 19:04, il y a 1 jour 4 heures

ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 06/11/2026 à 19:01, il y a 1 jour 4 heures

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Publié le 06/11/2026 à 19:00, il y a 1 jour 4 heures

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Publié le 06/11/2026 à 18:00, il y a 1 jour 5 heures

ICADE - CP - Notation crédit S&P

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 06/11/2026 à 22:15, il y a 1 jour 1 heure

Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Publié le 06/11/2026 à 13:00, il y a 1 jour 10 heures

Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Publié le 06/11/2026 à 12:30, il y a 1 jour 10 heures

Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Publié le 06/11/2026 à 12:30, il y a 1 jour 10 heures

Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Publié le 06/11/2026 à 10:00, il y a 1 jour 13 heures

Mongolia Tax Audit

Voir tout ACCESSWIRE

EQS Group

Publié le 07/11/2026 à 13:35, il y a 9 heures 49 minutes

Eurobattery Minerals board member and CEO remanded in custody in Sweden
Publié le 06/11/2026 à 20:15, il y a 1 jour 3 heures

African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Publié le 06/11/2026 à 20:15, il y a 1 jour 3 heures

L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Publié le 06/11/2026 à 19:15, il y a 1 jour 4 heures

EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Publié le 06/11/2026 à 19:00, il y a 1 jour 4 heures

Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet